INDV

Indivior PLC is a leading biopharmaceutical company headquartered in North Chesterfield, Virginia, focused on developing innovative treatments for opioid dependence and related disorders. Known for its pioneering work with buprenorphine-based therapies, Indivior aims to improve patient outcomes and tackle the complexities associated with opioid use disorder. The company demonstrates a strong commitment to public health through substantial investments in research and development, reinforcing its position as a transformative leader in addiction treatment. With a comprehensive product portfolio and a dedicated patient-centric approach, Indivior is well-prepared to address the evolving challenges within the healthcare landscape.